baber/WOPTO huggingface dataset:
Patent PT-1330092-E (PT)
Title: Multiresolution transmission
Inventor: OSHIMA MITSUAKI
IPC: H04N21/647
Filed: 1993-03-26
Abstract: At the transmitter side, carrier waves are modulated according to an input signal for producing relevant signal points in a signal space diagram. The input signal is divided into, two, first and second, data streams. The signal points are divided into signal point groups to which data of the first data stream are assigned. Also, data of the second data stream are assigned to the signal points of each signal point group. A difference in the transmission error rate between first and second data streams is developed by shifting the signal points to other positions in the space diagram. At the receiver side, the first and/or second data streams can be reconstructed from a received signal. In TV broadcast service, a TV signal is divided by a transmitter into, low and high, frequency band components which are designated as a first and a second data stream respectively. Upon receiving the TV signal, a receiver can reproduce only the low frequency band component or both the low and high frequency band components, depending on its capability.
Patent PT-1785054-E (PT)
Title: Retractable key-holder
Inventor: PLAZA LUIS MARIA AIZPURUA
IPC: A45C11/32
Filed: 2005-06-24
Abstract: The present invention relates to a concealable key ring, including: a carrying plate with two side walls, at least one key ring axle mounted transversely between the two side walls, where the key ring axle has at least one slot made axially on the surface of the axle, a positioning pin having a body and two ends, the body of the positioning pin is partially mounted in the slot with the body partially extruding beyond the slot and the two ends of the positioning pin are fixed on the two side walls, and multiple keys each having a head with a transverse hole in the head where the perimeter of the hole has at least one groove made transversely through the head.
Patent PT-2248975-E (PT)
Title: Clamping anchor for mounting fittings on a hollow profile of a window or door
Inventor: PARYS REMI EMIEL VAN
IPC: E05D5/02
Filed: 2010-04-27
Abstract: Clamping anchor for fixing a fitting on the profile (1-2) of a window or door, which is formed of an L-shaped body (6) having a leg (8) which is provided with an internal screw thread (9) extending in the longitudinal direction (X-X') of said leg (8), and a broadened head (10) on the end face of said leg (8), whereby the clamping anchor (5) has such a shape and dimensions that the body (6) can be put entirely through a round opening (11) of the profile (1-2) up to the thickened head (10), whereby the clamping anchor (5) can be hooked behind a wall surface (13) of the profile (1-2) with the other leg (7) and can be clamped with the latter by means of the tensile force of a screw (21).
Patent PT-2196199-E (PT)
Title: Phantom phenomena treatment
Inventor: KNIPPER-BREER MARLIES
IPC: A61K31/4422
Filed: 2006-01-19
Abstract: Use of a compound (I) interacting with brain-derived nerve growth factor (BDNF)-signal transduction cascade for the production of a medicament to treat phantom phenomena of acute tinnitus and/or phantom pain in human or animal. Independent claims are also included for: (1) diagnosing phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a biological sample, determining the level of the expression of BDNF in the biological sample, comparing the level with a reference value from a healthy organism, and correlating a level lying over the healthy organism with a positive diagnosis; and (2) treating phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a medicament that exhibits a substance interacting with BDNF signal transduction cascade, and applying the medicament locally to the organism, and optionally repeating the method. ACTIVITY : Auditory; Analgesic. MECHANISM OF ACTION : Brain-derived nerve growth factor (BDNF)-signal transduction cascade blocker; BDNF-signal transduction cascade inhibitor; Gamma aminobutyric acid receptor agonist; L-type-Ca ++>-channel antagonist; Cyclic adenosine monophosphate response element binding protein (CREP) antagonist; Glutamate antagonist; Mitogen activated protein-kinase-inhibitor; Calmodulin-dependent kinase-inhibitor; Tyrosine kinase linked receptor (trkB) antagonist. The ability of (I) to inhibit BDNF-signal transduction cascade was tested in cochlea. (I) Significantly removed the expressions of BNDF Exon-IV.
Patent PT-2387557-E (PT)
Title: Process for the preparation of n-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-n-methyl-acetamide
Inventor: ROSELL JUAN SALLARES
IPC: C07C231/12
Filed: 2010-01-11
Abstract: The present invention relates to a new process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluorophenyl]-N-methyl-acetamide (I) in a high yield and high purity, which is an intermediate in the synthesis of compounds with affinity for GABAA receptor. In this process, N-(5-acetyl-2-fluorophenyl)-N-methyl-acetamide (VI) is reacted with an excess of N,N-dimethylformamide dimethyl acetal (NNDMF-DMA). The present invention also provides a new process for the preparation of a compound with affinity for GABAA receptor, N-{2-fluoro-5-[3-(thiophene)-2-carbonyl-pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methyl-acetamide (II), which comprises the following steps: a) methylation of N-(5-acetyl-2-fluorophenyl)-N-acetamide (IV) with a methyl sulfonate, b) reaction of the resulting compound (VI) with NNDMF-DMA, and c) reaction of the resulting compound (I) with (5-amino-1H-pirazol-4-yl)thiophen-2-yl-methanone (III) in glacial acetic acid. The present invention also relates to new intermediate (VI).
Patent PT-2359826-E (PT)
Title: Combination of hmg-coa reductase inhibitor rosuvastatin with a phosphodiesterase 4 inhibitor, such as roflumilast, roflumilast-n-oxide for the treatment of inflammatory pulmonary diseases
Inventor: MARX DEGENHARD
IPC: A61K31/22
Filed: 2007-07-03
Abstract: The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease.
Patent PT-622183-E (PT)
Inventor: REINERS ULRICH
IPC: B32B27/08
Filed: 1994-04-18
Abstract: The present invention relates to multilayered, heat-sealable, recycled film comprising at least one scrap layer, a heat-sealable layer and an accompanying layer which is arranged either between the scrap layer and the heat-sealable layer or on the outside on the side facing away from the heat-sealable layer, where     - the film is thermoformable, - the scrap layer comprises polyamide (nylon)/polyolefin recyclate and an adhesion promoter, where the recyclate content in the scrap layer is from 60 to 98% by weight and the adhesion-promoter content is from 2 to 40% by weight, - the recyclate has a polyamide content of from 3 to 45% by weight, and - the heat-sealable layer has a single- or multilayer structure and comprises polyolefinic polymer or copolymer, where the layers can be identical or different, - the accompanying layer comprises polyamide, polyolefin, EVOH and/or adhesion promoter or an adhesion-promoter mixture
Patent PT-863527-E (PT)
Inventor: HOFSASS MARCEL
IPC: H01H37/54
Filed: 1997-11-14
Abstract: The temperature dependent switch has a bimetallic disc (31) that is retained within a formed ring (14) that is moulded into a plastic body (17). A bridging contact (29) is fixed to the centre of the disc and engages the fixed contacts (26,27) in one position. The contacts are fixed to contact carriers (24,25) that are metal pressings that are shaped to extend beyond the housing and provide a unit for external connection.
Patent PT-926100-E (PT)
Inventor: ZGORZELSKI WOLFGANG
IPC: C02F9/00
Filed: 1998-12-15
Abstract: Purification of 3 waste liquor fractions from the production of alcohols by aldol condensation and hydrogenation comprising extraction with 8-16C monoalcohols and/or 6-12C hydrocarbons in which before extraction, at least 2 of the 3 fractions are combined and adjusted to pH 0-6 and the resultant organic phase is optionally separated and 1 or more of the fractions is contacted with a coalescing filter during purification. Purification of waste liquor from the production of alcohols by aldol condensation and hydrogenation, which consists of 3 fractions, comprising: (1) the aqueous phase containing catalyst from aldol condensation; (2) the washing water from the purification of the  alpha , beta -unsaturated aldehyde obtained in the aldol condensation stage; and (3) the washing water from the purification of the residue from alcohol distillation. Purification involves extracting the waste liquor with 8-16C monoalcohols and/or 6-12 C hydrocarbons. Before extraction, at least 2 of the 3 fractions are combined and adjusted to pH 0-6, preferably 1-3 and the resultant organic phase is optionally separated and 1 or more of the fractions is contacted with a coalescing filter during purification.
Patent PT-1027339-E (PT)
Inventor: GUTMAN DANIELA
IPC: A61P25/00
Filed: 1998-10-02
Abstract: The present invention is directed to alkoxyalkylated ureides selected from N-methoxymethyl ethosuximide, N-methoxymethyl glutethimide, N-methoxymethyl-5,5-diphenylbarbituric and the therapeutical uses thereof.
Patent PT-1087061-E (PT)
Title: Paving tile for guidance of blind persons
Inventor: GRAHMBEEK MARIT ASTRID
IPC: E01F9/50
Filed: 1999-09-27
Abstract: The invention relates to a concrete pavement tile, which produces a clearly recognizable sound when touched with a blind's cane or a white stick. In practice it appears useful to incorporate sound sources in guide paths for the blind. The invention has solved this problem by providing a pavement tile (1) with an upper plate (3) of metal, which is supported by the tile at its circumference. The plate can be provided with regularly distributed outwardly projecting tears, bumps or ledges (6). Below the plate there is a sound space (2) which can be formed by pressing the plate, upwardly convex, whereas a hollow executed tile give the same effect. <IMAGE>
Patent PT-1085884-E (PT)
Inventor: THOMAS STIEFEL
IPC: A61K31/40
Filed: 1999-05-31
Abstract: The present invention relates to the use of selenium and/or a derivative thereof in combination with one or more cytostatics.It is the object of the present invention to provide a possibility of enhancing the effect of antitumor drugs, and to provide said drugs in a suitable form of administration.Said object is achieved by using selenium and/or at least one selenium compound for enhancing the effect of one or more cytostatics. This combination results in a synergistic, i.e. superadditive, enhancement of the effect. Furthermore, the present invention provides a kit containing selenium and/or at least one selenium compound and one or more cytostatics as a combination preparation for cytostatic therapy. The present invention can be used efficiently against various types of tumor cells, but especially against large-cell and small-cell bronchial carcinomas, adenocarcinomas, pancreatic carcinomas, prostatic carcinomas and hypemephromas.
Patent PT-1101089-E (PT)
Inventor: HEUFT BERNHARD
IPC: B07C5/34
Filed: 1999-07-29
Abstract: To test closed containers, e.g. with regard to residual air volume or the quality and tightness of the closures which are attached to containers, mechanical oscillations are excited in the closure, the mechanical oscillations are analyzed, measurement values are derived from this, these measurement values are compared with pre-set values for acceptable closures and a signal is produced which states whether the measurement value corresponds to a value for an acceptable closure. To increase the reliability of the test, the oscillation properties of the closure blanks (R) are also ascertained before their attachment to the containers (B) and the range of acceptable values of the closures (V) attached to the containers (B) is chosen according to the oscillation properties of the corresponding closure blank (R). The closure blanks (R) can be classified according to their oscillation properties.
Patent SG-9491-G (SG)
Title: A dispensing valve
IPC: E03D9/03
Filed: 1991-02-19
Abstract: A dispensing valve (3) provided in a chemical dispenser (5) for dispensing predetermined amounts of chemical into a lavatory cistern (3) is disclosed. The dispensing valve (9) seals an opening (43) in and dispenses liquid from the dispenser (5), the valve having a chamber (17) movable through the opening (43) between a filling position in which the chamber (17) is fillable with chemical from the dispenser (5) and a discharge position in which chemical held in the chamber (17) may be discharged, the chamber (17) being provided with surfaces sealing the opening in both said positions and further having an adjustable filling volume.
Patent SG-30614-G (SG)
Title: Multi-system paging device with power conservation
Inventor: DAVIS WALTER LEE
IPC: H04W88/02
Filed: 1981-08-31
Abstract: An battery powered, adaptive signal decoder is disclosed which is capable of processing detected encoded signals in accordance with a plurality of decoding schemes. The decoder has an equivalent microcomputer implementation. Energy conservation means operating independently of the detected signals acts to conserve the energy of the battery.
Patent IE-820224-L (IE)
Title: Salts of penicillanic acid 1, 1-dioxide
IPC: C07D499/00
Filed: 1982-02-01
Abstract: The 1:2 N,N'-dibenzylethylenediamine, the N-benzyl-2-phenylethylamine and the dibenzylamine salts of penicillanic acid 1,1-dioxide, a well-known betalactamase inhibitor, are sparingly soluble in water. Accordingly they are valuable as slow release (depot) forms of penicillanic acid 1,1-dioxide, particularly for use in conjunction with slow release (depot) forms of penicillin and cephalosporin antibiotics, in the chemotherapy of bacterial infections in mammals.
[US4331599A]
Patent IE-900437-L (IE)
Title: A method of freezing red blood cells
IPC: A61K35/18
Filed: 1990-02-07
Abstract: A method of freezing a standard donor unit of red blood cells such that it can be stored for long periods and subsequently recovered in a form pure enough for transfusion purposes uses red blood cells separated from plasma and platelets, as obtainable by centrifuging whole blood. The red blood cells are treated so that they have a Packed Cell Volume of not less that 90% and are added to a freezing bag (13) containing HES solution such that the ratio of HES/red blood cells is no more that 7% (preferably 6%) w/v. The bag (13) is placed in a freezing frame (20, 21), which is adapted to maintain the thickness of the contents of the bag constant, and the frame is placed in liquid nitrogen. <IMAGE>
Patent IE-40753-L (IE)
Title: Quinoxalylthiono - thiolphosphoric (phosphonic) acid esters;¹insecticides
IPC: A01N57/16
Filed: 1975-03-06
Abstract: 1447212 Pesticidal phosphorus-containing quinoxaline derivatives BAYER AG 6 March 1975 [7 March 1974] 9379/75 Heading C2P Novel compounds of Formula I: where R is C 1-5 alkoxy or C 1-4 alkyl and R<SP>1</SP> is C 1-6 alkyl may be prepared by reacting a compound of Formula II: with 6-hydroxyquinoxaline in the presence of an acid acceptor or with a salt of 6-hydroxyquinoxaline. The compounds of Formula I have insecticidal and acaricidal properties and may be used as the active ingredients in conventional pesticidal compositions.
[GB1447212A]
Patent IE-850863-L (IE)
Title: Human polypeptide and dna coding therefor
IPC: C12R1/19
Filed: 1985-04-04
Abstract: The invention concerns a human physiologically active polypeptide, a composition of matter composition of matter comprising the same, a DNA coding for a polypeptide having TNF activity, microorganisms and plasmids comprising the DNA and a method for the production of the polypeptide.
[EP0354592A1]
Patent IE-33195-L (IE)
Title: Bending glass sheets
IPC: C03B23/031
Filed: 1969-07-07
Abstract: 1,260,472. Bending glass sheets. TRIPLEX SAFETY GLASS CO. Ltd., T. CARTLEDGE, and J. PICKARD. 30 June, 1969 [12 July, 1968], No. 33394/68. Heading C1M. A heated glass sheet 1 is bent between two complementary dies, one (5) of the frame type and another (4) which is solid and which contains one or more controllable electrical heating element(s) 6 which are employed to control the temperature of the solid bending die and hence the rate of heat transfer from the glass sheet to the die. It is intended that the rate of heat transfer should be adjusted so that heat losses from the two sides of the sheet are equalized to eliminate spring-back in the bent sheet. Temperature sensing elements 7 are provided and are used to control the heaters, e.g. by means of variable transformers. The die 4 may be of cast refractory ceramic or metal or metal sheet and the die 5 of metal. The die 4 may be additionally covered with woven glass fibre cloth or by a boron nitride coating. The dies may give double curvature to the glass sheet.
[GB1260472A]
Patent FI-813089-L (FI)
Inventor: BOBERG MICHAEL
IPC: C07D498/04
Filed: 1981-10-06
Abstract: beta -Lactam antibiotics of the formula   <IMAGE>   in which A is a hydrogen atom, an optionally substituted alkyl, alkenyl, alkinyl or cycloalkyl group, a substituted or unsubstituted phenyl ring, a polycyclic aromatic ring or an optionally substituted heterocyclic 5-membered or 6-membered ring with 1 to 4 hetero-atoms, Y is <IMAGE>  X is a sulphur or oxygen atom, T is an organic radical, and Z is a hydrogen atom or a C1 to C6 alkoxy group, or an ester or salt thereof.
Patent FI-831979-L (FI)
Inventor: JOHANSSON ERLAND
IPC: A23L1/30
Filed: 1983-06-02
Abstract: A composition for human supply of selenium as a trace element and comprising a selenium (IV) compound or seleno-methionine+a selenium (IV) compound. The admixture into the composition of vitamins E, B2, B6 and B12 allows the body to assimilate selenium. The composition may also be used in solutions for storage of organs, in media for cell cultivation and in nutritive solutions for storage of blood components.
Patent IE-851102-L (IE)
Title: Adhesin antigens, antibodies thereto, and vaccine
IPC: C07K14/24
Filed: 1985-05-02
Abstract: An antigen which, as its major immunizing component, comprises a determinant of an adhesin polypeptide or an immunogenically active subsequence thereof or a precursor therefor which is convertible to an immunogenically active form, antibodies against which determinant react with the adhesin polypeptide produced by pathogenic adhesin-forming bacteria which adhere to mammalian tissue, antibodies against such antigen, and DNA expressing, as a principal gene product thereof, such antigen.
Patent IE-36656-L (IE)
Title: Synthetic polymer fibrils
IPC: D01D7/00
Filed: 1972-08-25
Abstract: A process for recovering synthetic polymer fibrils which are in the presence of vapors of an organic solvent, by depositing the fibrils on a moving porous support in a closed vessel and continuously extracting the solvent vapors from the vessel by suction.
[US3883630A]
Patent IE-38317-L (IE)
Title: Benzopyranobenzopyrans
IPC: C07D493/02
Filed: 1973-08-29
Abstract: 1439990 Condensed benzopyran derivatives and pharmaceutical uses thereof BOEHRINGER INGELHEIM GmbH 28 Aug 1973 [29 Aug 1972] 40417/73 Heading C2C The invention comprises compounds of formula (wherein R 1 represents a hydrogen atom or a (C 1-4 ) alkyl group; R 2 , R 4 , R 5 which may be the same or different, each represents a hydrogen or halogen atom or a (C 1-4 ) alkyl, hydroxy, (C 1-4 ) alkoxy, (C 2-5 ) acyloxy, nitro or -SO 3 H group; and R 3 and R 6 , which may be the same or different, each represents a hydrogen or halogen atom or a (C 1-4 ) alkyl, hydroxy, (C 1-4 ) alkoxy, (C 2-5 ) acyloxy, nitro, hydroxycarbonylmethoxy, #-hydroxyethoxy, #-aminoethoxy or -SO 3 H group) and salts thereof. These compounds may be obtained by treating a compound of formula (wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined above) with an oxalic acid ester, e.g. diethyloxalate. These compounds may also be obtained by cyclizing a compound of formula in the presence of a strong mineral acid such as H 2 SO 4 The starting material of Formula II may be obtained by (a) a Fries arrangement of the ester of formula The ester of Formula (2) is obtained by treating a phenol of formula with acetic anhydride in the presence of AlCl 3 . The phenols of Formula I may be obtained by treating a lactone of formula with diborane boron trifluoride (when R 1 represents hydrogen); or with Grignard alkylating reagent (when R 1 represents an alkyl group) The intermediates of Formula III may be obtained by reacting the phenol of Formula (1) with dimethylacetylene dicarbonic acid in a basic medium, (for detailed methods see Example 2). The invention also relates to a pharmaceutical composition comprising at least one compound of Formula I or a physiologically compatible salt thereof in association with a pharmaceutical carrier. These compositions are reported to have antiallergic properties and may be suitable nasal, topical, parenteral or enteral administration.
[GB1439990A]
Patent IE-801631-L (IE)
Title: Drive coupling arrangement
IPC: F16D41/12
Filed: 1980-08-05
Abstract: In a drive coupling arrangement, a first gear wheel 16 meshes both with a second gear wheel 4 and a third gear wheel 6. The second gear wheel 4 has an odd number of internal teeth 8. The third gear wheel 6 carries two resiliently biassed detents 7, controlled by a lever 10 and electromagnetically operated catch 12. Only a segment of the third gear wheel 6 meshes with the first gear wheel 4. Upon actuating the lever 10, one of the detents 7 engages the internal teeth 8, such that the third gear wheel 6 is entrained by the continuously driven second gear wheel 4. Thereafter, the third gear wheel 6 meshes with, and is driven by the first gear wheel 16. When the third gear wheel 6 has completed one revolution, the detents 7 are released via the lever 10, and the third gear wheel 6 remains in a rest position until the lever 10 is again actuated. <??>The invention is particularly applicable to the drive coupling of a transport mechanism 2, and a control drum 1 for a printing mechanism, for a postal franking machine. <IMAGE> 
[GB2056610A]
Patent IE-821669-L (IE)
Title: Oral absorption enhancement of carboxylic acid¹pharmaceuticals using dioxolenes
IPC: C07F7/08
Filed: 1982-07-12
Abstract: The (5-R-2-oxo-1,3-dioxolen-4-yl)methyl moiety: <CHEM> wherein R is loweralkyl of 1-6 carbon atoms, especially methyl or t-butyl; when utilized as an ester on a pharmaceutical having a carboxylic acid functionality, enhances oral absorption of the pharmaceutical. This effect is applicable to a broad range of pharmaceutically active substances, including antibiotics, and antihypertensives as well as other classes of therapeutic agents.
[EP0070013A1]
Patent IE-40783-L (IE)
Title: Treating timber.
IPC: B27K5/02
Filed: 1974-08-13
Abstract: An agent for stabilization of a decorative finish is incorporated in a timber preservative composition comprising a preservative e.g., fungicide, insecticide or fire retardant in an organic solvent e.g. white spirit, chlorinated hydrocarbon such as methylene chloride or a liquified butane or propane for use in a double vacuum treatment of the timber. The agent may be an alkyd resin or colloidal pigment of a defined mean particle size, or both.
[US4062991A]